Diclofenac diethylamine 2.32% gel

DRUG2 trials

Sponsors

Novartis, GlaxoSmithKline

Conditions

Ankle SprainPain

Phase 2

Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel in Patients With Acute Ankle Sprain

CompletedNCT00573768

NovartisAnkle Sprain

Start: 2007-11-30End: 2008-07-31Updated: 2012-04-20

Phase 3

Voltaren Emulgel 2% Acute Ankle Sprain Non Inferiority Study

CompletedNCT04052620

GlaxoSmithKlinePain

Start: 2019-10-24End: 2020-11-12Updated: 2022-04-12

Related Papers

Randomized, double-blind, noninferiority study of diclofenac diethylamine 2.32% gel applied twice daily versus diclofenac diethylamine 1.16% gel applied four times daily in patients with acute ankle sprain

BMC Musculoskeletal Disorders2022-12-244 citations